GVOKE

Serial Number 90165932
606

Registration Progress

Application Filed
Sep 8, 2020
Under Examination
Apr 20, 2021
Approved for Publication
Feb 23, 2021
Published for Opposition
Feb 23, 2021
Registered

Trademark Image

GVOKE

Basic Information

Serial Number
90165932
Filing Date
September 8, 2020
Published for Opposition
February 23, 2021
Abandonment Date
May 27, 2024
Drawing Code
3

Status Summary

Current Status
Inactive
Status Code
606
Status Date
May 27, 2024
Classes
005

Rights Holder

Xeris Pharmaceuticals, Inc.

03
Address
180 N LaSalle Street, Suite 1810
Chicago, IL 60601

Ownership History

Xeris Pharmaceuticals, Inc.

Original Applicant
03
Chicago, IL

Xeris Pharmaceuticals, Inc.

Owner at Publication
03
Chicago, IL

Legal Representation

Attorney
Tracy-Gene G. Durkin

USPTO Deadlines

All Deadlines Cleared

All 2 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

38 events
Date Code Type Description Documents
Jul 12, 2024 MAB6 E ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Loading...
May 27, 2024 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Oct 31, 2023 NOAC E CORRECTED NOA E-MAILED Loading...
Oct 31, 2023 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Oct 30, 2023 EX5G S SOU EXTENSION 5 GRANTED Loading...
Oct 30, 2023 DPCC D DIVISIONAL PROCESSING COMPLETE Loading...
Oct 30, 2023 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Oct 20, 2023 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Oct 20, 2023 EXT5 S SOU EXTENSION 5 FILED Loading...
Oct 20, 2023 DRRR I DIVISIONAL REQUEST RECEIVED Loading...
Oct 20, 2023 ERTD I TEAS REQUEST TO DIVIDE RECEIVED Loading...
Apr 20, 2023 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Apr 18, 2023 EX4G S SOU EXTENSION 4 GRANTED Loading...
Apr 18, 2023 EXT4 S SOU EXTENSION 4 FILED Loading...
Apr 18, 2023 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Sep 24, 2022 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Sep 22, 2022 EX3G S SOU EXTENSION 3 GRANTED Loading...
Sep 22, 2022 EXT3 S SOU EXTENSION 3 FILED Loading...
Sep 22, 2022 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jun 23, 2022 ASCK I ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY Loading...
Apr 9, 2022 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Apr 7, 2022 EX2G S SOU EXTENSION 2 GRANTED Loading...
Apr 7, 2022 EXT2 S SOU EXTENSION 2 FILED Loading...
Apr 7, 2022 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Oct 22, 2021 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Oct 20, 2021 EX1G S SOU EXTENSION 1 GRANTED Loading...
Oct 20, 2021 EXT1 S SOU EXTENSION 1 FILED Loading...
Oct 20, 2021 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
May 12, 2021 ASCK I ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY Loading...
Apr 20, 2021 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Feb 23, 2021 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Feb 23, 2021 PUBO A PUBLISHED FOR OPPOSITION Loading...
Feb 3, 2021 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Jan 15, 2021 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jan 14, 2021 DOCK D ASSIGNED TO EXAMINER Loading...
Oct 15, 2020 MDSC E NOTICE OF DESIGN SEARCH CODE E-MAILED Loading...
Oct 14, 2020 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Sep 11, 2020 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical products for the treatment of diabetes and metabolic diseases; medical apparatus, namely, a drug delivery device prefilled with pharmaceutical products for the treatment of diabetes and metabolic diseases; pre-filled syringes and vials containing pharmaceutical preparations for the treatment of diabetes and metabolic diseases

Additional Information

Design Mark
The mark consists of Two overlapping droplets positioned within a semi-circle, followed by the term "GVOKE".

Classification

International Classes
005